Aortic Coarctation Market Overview

Coarctation of the aorta (CoA) in layman’s term is contraction of aorta; the condition accounts for close 5-8% of all congenital heart defects. There is growing market for the treatment of disease mainly due to rising prevalence. As per the report published by Market Research Future (MRFR) the global Aortic Coarctation Market Share is set to demonstrate a compound annual growth rate (CAGR) of 5.6% till 2030.

CoA may develop as an isolated defect or may be caused by some other abrasion like ventricular septal defect (VSD) and bicuspid aortic valve. In several cases, the issue is identified in infantile period with symptoms arising within the first twelve month after birth.

According to the information available in US National Library of Medicine National Institutes of Health, CoA is a relative common type of congenital heart disease. CoA incidence rate in around 3 cases per 10000 births. It is considered as a diverse form of abrasion which may be found across all age groups. In 1944, a surgical repair for aortic coarctation was defined for the first time. Today, a slew of surgical techniques is available for the condition. Over the years, the treatment for CoA has improved substantially. Some of the common techniques include endovascular stent placement and transcatheter balloon angioplasty. These procedures are highly advanced and are among minimally invasive approaches. However, determination of the treatment approach entirely depends on the severity of the condition.

Request Free Sample Copy at:


Aortic Coarctation Market Segmentation


MRFR’s report includes a detailed segmental analysis of the market based on treatment, end user and region.

On the basis of treatment, the market has been segmented into subclavian flap aortoplasty, patch aortoplasty, balloon angioplasty and other. Of these, the balloon angioplasty segment represents relatively high market share and is expected to retain its top position over 2022. On the basis of end user, the market has been segmented into cardiac institutes, clinic, hospital and others.

Aortic Coarctation Market Regional Analysis

On the basis of regions, the global market for aortic coarctation has been segmented into North America, Latin America, Europe, the Middle East & Africa (MEA) and Asia Pacific (APAC). Of these, North America represent the largest market for aortic coarctation market. During the forecast period, the market in North America is expected to exhibit a strong growth. Fuelled by the increased prevalence of heart disorders, the market in North America is expected to remain highly attractive in the years ahead. Meanwhile, Europe is expected retain its second spot over 2022. High healthcare expenditure and existence of an advanced healthcare system favours the market in the region. APAC has also emerged as a fast-growing market for aortic coarctation in recent years. Rising healthcare standard in countries such as China and India is creating opportunities for market in APAC.

Global Aortic Coarctation Market: Competition Analysis

Some of the key companies operating in the global market for aortic coarctation include Medtronic (Ireland), Clada Medical Devices (Ireland), Creganna (Ireland), Braile Biomedica (Brazil), B. Braun Melsungen AG (Germany) and Freudenberg Medical, LLC (Germany).

Browse Detailed TOC with COVID-19 Impact Analysis at:


About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071